Import Botox — Buy in Bulk from Supplier in China

Botox from Qufu Hantang Biotechnology Co., Ltd. is a botulinum toxin injectable supplied in vials containing 150 IU (international units) per container. The product is designated for both aesthetic and therapeutic administration, with a reported duration of clinical effect between three and six months post-injection. Cold chain storage is required throughout distribution to preserve neurotoxin stability and biological activity. The supplier sources this as an imported-tier product, though buyers should independently verify the manufacturing origin and chain of custody documentation. Each vial is intended for single-patient use after reconstitution with sterile, preservative-free saline.

The active pharmaceutical ingredient is botulinum toxin type A, a 150 kDa neurotoxic protein complex produced by fermentation of Clostridium botulinum. Standard reconstitution follows aseptic technique with 0.9% sodium chloride injection to achieve the desired unit concentration per treatment site. Typical dilution ranges from 1 to 4 mL per vial, though this varies by clinical protocol and target muscle mass. The formulation contains human serum albumin and sodium chloride as excipients; buyers should confirm the complete Certificate of Analysis for endotoxin levels, potency uniformity, and protein load. No preservative is present, so reconstituted material must be used within hours and discarded according to biohazard protocols.

This product serves cosmetic clinics performing glabellar line, crow's feet, and forehead smoothing procedures, as well as medical practices treating cervical dystonia, blepharospasm, chronic migraine, hyperhidrosis, and sp waiter-specific indications. The buyer base includes dermatology practices, plastic surgery centres, medical spas with supervising physicians, and hospital neurology departments. Import procurement requires temperature-controlled freight, customs clearance with pharmaceutical import permits, and compliance with national regulatory frameworks for prescription biologicals. Buyers must confirm with Qufu Hantang Biotechnology Co., Ltd. whether the specific vial presentation includes patient information leaflets, batch traceability codes, and cold chain monitoring documentation.

Qufu Hantang Biotechnology Co., Ltd. maintains a registered address at No.10, Chunqiu Road, Jining 273100, Shandong Province, China. The supplier operates on an imported-tier basis, which indicates they distribute product originally manufactured elsewhere rather than producing the active biological substance in-house. The trust tier is classified as harbor, a baseline designation that does not constitute verification of manufacturing capability or quality systems. The response rate stands at 0.00% with zero reported average response hours, meaning prospective buyers should anticipate delayed or absent communication and plan sourcing timelines accordingly. No information is provided about the company's years in operation, number of employees, revenue scale, or client references.

The supplier listing presents Botox as a premium product with flexible minimum order quantities, though exact MOQ figures are not specified in the source data and must be confirmed directly. Claims of ISO and FDA compliance appear in the source description, but buyers should request current certificates with scope, certificate numbers, and validity dates rather than relying on assertion. The company does not disclose its upstream manufacturer, batch release testing protocols, or pharmacovigilance arrangements. Any procurement decision should be preceded by supplier qualification, audit scheduling, and independent verification of regulatory documentation through the appropriate national authority in China and the buyer's destination country.